Final Results of the KRISTINE Trial in HER2-Positive Breast Cancer
This phase III trial tested T-DM1 plus pertuzumab vs chemotherapy and dual HER2 blockade in patients with HER2+ breast cancer.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Dave Levitan Source Type: news